It is intriguing to speculate whether overexpression of G6PD in nonmetastatic prostate cancer would be sufficient to drive bone metastasis, a challenging experiment due to the lack of well-characterized in vivo models in which prostate cancer spreads from the primary tumor site to the bone. This evidence concerns the gene G6PD and prostate carcinoma.